GlassScriptPhysician profile
Alexa S Lessow
NPI 1770544009
$782.20
in general payments reported to CMS, 2019-2025
10 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.19 · 2020: $54.23 · 2021: $91.91 · 2022: $218 · 2023: $18.86 · 2024: $241 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $214.72 | 2020-2025 | |
| Glaxosmithkline, LLC. | $147.36 | 2022-2024 | Nucala |
| Alk-Abello, INC | $94.76 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $93.40 | 2022-2025 | Dupixent |
| Kaleo, INC. | $71.70 | 2022-2024 | Auvi-Q |
| Stryker Corporation | $56.57 | 2022 | |
| Intersect Ent, INC. | $41.27 | 2021 | |
| Allergan, INC. | $23.47 | 2022 | |
| Hikma Pharmaceuticals USA | $19.82 | 2024 | Ryaltris |
| Optinose US, INC. | $19.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Lessow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.